Latest Insider Transactions at Liquidia Corp (LQDA)
This section provides a real-time view of insider transactions for Liquidia Corp (LQDA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Liquidia Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Liquidia Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
14,777
-3.46%
|
$236,432
$16.97 P/Share
|
|
Jun 04
2025
|
Roger Jeffs Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,610
-2.85%
|
$489,760
$16.97 P/Share
|
|
Jun 03
2025
|
Rajeev Saggar Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,654
+5.92%
|
-
|
|
Jun 03
2025
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,539
+6.29%
|
-
|
|
Jun 03
2025
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
18,792
+3.08%
|
-
|
|
Jun 03
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,371
+5.9%
|
-
|
|
Jun 03
2025
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,141
+6.39%
|
-
|
|
Jun 03
2025
|
Roger Jeffs Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69,169
+6.04%
|
-
|
|
Jun 02
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
859
-0.22%
|
$13,744
$16.74 P/Share
|
|
Jun 02
2025
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
581
-0.27%
|
$9,296
$16.74 P/Share
|
|
Jun 02
2025
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
923
-0.16%
|
$14,768
$16.74 P/Share
|
|
Jun 02
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
451
-0.24%
|
$7,216
$16.74 P/Share
|
|
May 30
2025
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.58%
|
-
|
|
May 30
2025
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+0.86%
|
-
|
|
May 30
2025
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.41%
|
-
|
|
May 30
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,563
+0.84%
|
-
|
|
Apr 28
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
455
-0.25%
|
$6,370
$14.24 P/Share
|
|
Apr 21
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,450
-0.92%
|
$31,850
$13.67 P/Share
|
|
Apr 15
2025
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,406
-1.56%
|
$44,278
$13.57 P/Share
|
|
Apr 14
2025
|
Roger Jeffs Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,130
-1.38%
|
$183,690
$13.57 P/Share
|
|
Apr 14
2025
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
5,964
-1.03%
|
$77,532
$13.57 P/Share
|
|
Apr 14
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,714
-1.38%
|
$48,282
$13.57 P/Share
|
|
Apr 14
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
8,283
-2.05%
|
$107,679
$13.57 P/Share
|
|
Apr 14
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,856
-1.0%
|
$24,128
$13.57 P/Share
|
|
Apr 11
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,906
+2.06%
|
-
|
|
Mar 03
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
451
-0.25%
|
$6,765
$15.45 P/Share
|
|
Mar 03
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
874
-0.22%
|
$13,110
$15.45 P/Share
|
|
Mar 03
2025
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
592
-0.27%
|
$8,880
$15.45 P/Share
|
|
Mar 03
2025
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
930
-0.16%
|
$13,950
$15.45 P/Share
|
|
Feb 28
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,562
+0.85%
|
-
|
|
Feb 28
2025
|
Michael Kaseta CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.57%
|
-
|
|
Feb 28
2025
|
Scott Moomaw Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+0.85%
|
-
|
|
Feb 28
2025
|
Russell Schundler General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+0.4%
|
-
|
|
Jan 27
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
445
-0.25%
|
$6,230
$14.2 P/Share
|
|
Jan 21
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,445
-0.9%
|
$31,785
$13.0 P/Share
|
|
Jan 14
2025
|
Russell Schundler General Counsel |
SELL
Open market or private sale
|
Direct |
16,393
-2.78%
|
$180,323
$11.78 P/Share
|
|
Jan 14
2025
|
Roger Jeffs Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,343
-2.15%
|
$245,773
$11.78 P/Share
|
|
Jan 14
2025
|
Jason Adair Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,809
-2.6%
|
$52,899
$11.78 P/Share
|
|
Jan 14
2025
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
23,370
-5.5%
|
$257,070
$11.78 P/Share
|
|
Jan 14
2025
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
8,362
-3.74%
|
$91,982
$11.78 P/Share
|
|
Jan 14
2025
|
Rajeev Saggar Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,249
-2.26%
|
$68,739
$11.78 P/Share
|
|
Jan 11
2025
|
Russell Schundler General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
102,543
+14.81%
|
-
|
|
Jan 11
2025
|
Roger Jeffs Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
229,327
+18.05%
|
-
|
|
Jan 11
2025
|
Jason Adair Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,906
+2.07%
|
-
|
|
Jan 11
2025
|
Jason Adair Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,895
+25.47%
|
-
|
|
Jan 11
2025
|
Michael Kaseta CFO and COO |
BUY
Grant, award, or other acquisition
|
Direct |
112,797
+20.97%
|
-
|
|
Jan 11
2025
|
Scott Moomaw Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69,729
+23.75%
|
-
|
|
Jan 11
2025
|
Rajeev Saggar Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
71,780
+20.6%
|
-
|
|
Dec 02
2024
|
Michael Kaseta CFO and COO |
SELL
Open market or private sale
|
Direct |
1,091
-0.35%
|
$12,001
$11.51 P/Share
|
|
Dec 02
2024
|
Scott Moomaw Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
546
-0.35%
|
$6,006
$11.51 P/Share
|